SEC Form 4 · accession 0001465825-15-000004
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ashok G Nigalaye
Director
Period of report
Sep 14, 2015
Accepted (ET)
Oct 20, 2015 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $0.0625 | Sep 14, 2015 | G | 454,665 | D | Jun 3, 2009 | Jun 3, 2016 | Common Stock | 454,665 | 0 | D |
| Warrant | $0.0625 | Sep 14, 2015 | G | 2,684,137 | D | Oct 30, 2009 | Oct 30, 2016 | Common Stock | 2,684,137 | 0 | D |
| Warrant | $0.0625 | Sep 14, 2015 | G | 1,324,333 | D | Oct 30, 2009 | Oct 30, 2016 | Common Stock | 1,324,333 | 0 | D |
| Warrant | $0.0625 | Sep 14, 2015 | G | 5,697,710 | D | Mar 31, 2011 | Mar 31, 2018 | Common Stock | 5,697,710 | 0 | D |
Remarks
Dr. Nigalaye resigned as a director effective June 5, 2015.